1511 - 1520 of 5877 Results
Title
Year
- Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON Trial2022OPENTitle: Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON TrialJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 3Start Page: 1409End Page: 1425Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00371-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00371-7.pdfCitation Count: 6
- The Association of CSF sTREM2 With Cognitive Decline and Its Dynamic Change in Parkinson's Disease: Analysis of the PPMI Cohort2022OPENTitle: The Association of CSF sTREM2 With Cognitive Decline and Its Dynamic Change in Parkinson's Disease: Analysis of the PPMI CohortJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.892493Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.892493/pdfCitation Count: 16
-
OPENTitle: Racial disparities in hypertension management among multiple sclerosis patientsJournal Name: Multiple Sclerosis and Related DisordersPublisher: Elsevier BVVol: 64Issue #:Start Page: 103972End Page: 103972Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.msard.2022.103972Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308758Citation Count: 10
- Relationships of self-reported and objective measures of sleep, sleepiness, and sleep quality in Parkinson's disease2022OPENTitle: Relationships of self-reported and objective measures of sleep, sleepiness, and sleep quality in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 57End Page: 61Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.009Best OA location URL: http://manuscript.elsevier.com/S1353802022001924/pdf/S1353802022001924.pdfCitation Count: 5
- Cortical and Subthalamic Nucleus Spectral Changes During Limb Movements in Parkinson's Disease Patients with and Without Dystonia2022OPENTitle: Cortical and Subthalamic Nucleus Spectral Changes During Limb Movements in Parkinson's Disease Patients with and Without DystoniaJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1683End Page: 1692Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29057Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29057Citation Count: 7
- Integrating Data Directly into Publications with Augmented Reality and Web-Based Technologies – Schol-AR2022OPENTitle: Integrating Data Directly into Publications with Augmented Reality and Web-Based Technologies – Schol-ARJournal Name: Scientific DataPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41597-022-01426-yBest OA location URL: https://www.nature.com/articles/s41597-022-01426-y.pdfCitation Count: 7
- Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment2022OPENTitle: Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairmentJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 4Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcac155Best OA location URL: https://academic.oup.com/braincomms/article-pdf/4/4/fcac155/45028282/fcac155.pdfCitation Count: 26
- Association Between Dopaminergic Medications and the Evolution of REM Sleep Behavior Disorder in Parkinson's Disease2022OPENTitle: Association Between Dopaminergic Medications and the Evolution of REM Sleep Behavior Disorder in Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.880583Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.880583/pdfCitation Count: 4
- Associations of Sleep Disorders With Depressive Symptoms in Early and Prodromal Parkinson’s Disease2022OPENTitle: Associations of Sleep Disorders With Depressive Symptoms in Early and Prodromal Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.898149Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.898149/pdfCitation Count: 4
- Breakthrough News in Adenoviral Vector‐Mediated AADC Gene Therapy: Lessons from the Success in AADC Deficiency and Possible Future Applications2022OPENTitle: Breakthrough News in Adenoviral Vector‐Mediated AADC Gene Therapy: Lessons from the Success in AADC Deficiency and Possible Future ApplicationsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 6Start Page: 737End Page: 738Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13503Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13503Citation Count: 1